COMPARATIVE STUDY OF INTRATHECAL BUPIVACAINE WITH OR WITHOUT NEOSTIGMINE FOR INFRAUMBILICAL SURGERIES
Journal Title: Journal of Evidence Based Medicine and Healthcare - Year 2017, Vol 4, Issue 49
Abstract
BACKGROUND Spinal anaesthesia requires a small volume of drug to produce profound sensory analgesia and motor blockade, but has limited duration of action. An adjuvant to local anaesthetic agent produces a better quality regional block. Intrathecal (IT) neostigmine has been used as an adjunct to Spinal Anaesthesia (SA) for the prevention of acute perioperative pain. It has been shown to potentiate opioid analgesia.1 According to recent literature, the inhibition of acetylcholine degradation by neostigmine enhances the descending control of afferent nociceptive stimuli and provides new approach for enhancement of desirable analgesia with few dose-related side effects.2 The use of neostigmine intrathecally does not cause any hypotension, sedation, respiratory depression or neurological dysfunction.2 Hence, we studied to compare the effect of intrathecal neostigmine 50 µg added to intrathecal hyperbaric bupivacaine with regard to sensory characteristics, motor characteristics and side effects. MATERIALS AND METHODS This was a prospective, randomised controlled double blinded study in 60 patients posted for infraumbilical surgeries belonging to ASA I and II status and aged between 18 to 60 years. One group received intrathecal 0.5% hyperbaric bupivacaine 3 mL (15 mg) group A and second group received preservative-free neostigmine 50 µg with 3 mL (15 mg) of intrathecal 0.5% hyperbaric bupivacaine group B and they were compared with regard to sensory characteristics, motor characteristics and side effects. RESULTS The addition of neostigmine 50 ug to hyperbaric bupivacaine prolonged mean duration of analgesia from the time of onset of complete sensory blockade to the time at which rescue analgesic was given using VAS score. It was 322.2 + 25.76 (SD) min. in the neostigmine group suggesting a statistically significant delay in onset of breakthrough pain between group A and group B. CONCLUSION Intrathecal neostigmine 50 ug with bupivacaine produces a good sensory and motor block for the surgical procedure with safe, durable and predictable postoperative analgesia. Administration of intrathecal neostigmine as an adjuvant to bupivacaine produces effective, prolonged and haemodynamically stable postoperative analgesia as compared to administration of intrathecal bupivacaine alone.2
Authors and Affiliations
Dadichiluka Veeragouri Sankararao, Kesava Vamsikrishna Bhairavabhatla
MUCINOUS CYSTADENOMA WITH BRENNER TUMOR: A CASE REPORT
Surface epithelial tumors are the most common neoplasms of the ovary. Among these, mucinous tumors accounts for 14% of ovarian tumors. Coexistence of mucinous tumor with other surface epithelial tumors is rare. We report...
INTRACRANIAL AND INTRASPINAL TUMOURS: REVIEW OF MRI FINDINGS IN A RARE NF-2 CASE
Neurofibromatosis type 2 is a rare autosomal dominant syndrome, characterized by multiple intracranial and intraspinal tumours associated with ocular abnormalities. The most common tumor associated with the disease is th...
SIXTY YEARS AFTER INHALATIONAL DEVICES- WHERE DO WE STAND?
BACKGROUND Bronchial asthma and chronic obstructive pulmonary disease are the Common Respiratory Diseases (CRD’s). Drugs delivered through inhaler devices are the backbone for treatment of CRD’s. Inhaler technique errors...
IDENTIFICATION OF FUNGAL PATHOGENS IN BURNS PATIENTS WITH REFERENCE TO CANDIDA
BACKGROUND: Infection with microbes in burns patients is a leading cause of morbidity and mortality. The present study was aimed to study the fungal pathogens from infected burns patients periodically during their stay i...
TO STUDY THE EFFICACY OF LAPAROSCOPY IN CHRONIC ABDOMINAL PAIN
“To study the efficacy of diagnostic laparoscopy is undiagnosed chronic abdominal pain’’ in a prospective study of diagnostic laparoscopy in identifying the etiology of undiagnosed chronic abdominal pain and to study the...